The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients
Authors:
- Jan LötvallJLJan Lötvall
- Mona PalmqvistMPMona Palmqvist
- Peter ArvidssonPAPeter Arvidsson
- Alan MaloneyAMAlan Maloney
- G.PIetro VentrescaGVG.PIetro Ventresca
- Jonathan WardJWJonathan Ward
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 108 (5) , 726-731
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patientsJournal of Allergy and Clinical Immunology, 1999
- Targeting Drugs to the Airways by Different Inhalation DevicesBioDrugs, 1999
- Determination of the enantiomers of salbutamol and its 4-O-sulphate metabolites in biological matrices by chiral liquid chromatography tandem mass spectrometryRapid Communications in Mass Spectrometry, 1998
- Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma☆☆☆★★★Journal of Allergy and Clinical Immunology, 1998
- Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.Thorax, 1997
- Dose-Response of Inhaled Drugs in AsthmaClinical Pharmacokinetics, 1997
- Comparison ofR-, S-, andRS-albuterol interaction with human β1 and β2-adrenergic receptorsClinical Reviews in Allergy & Immunology, 1996
- AlbuterolClinical Reviews in Allergy & Immunology, 1996
- Enantioselective disposition of salbutamol in man following oral and intravenous administrationBritish Journal of Clinical Pharmacology, 1996
- Salbutamol in the treatment of asthmaThe Lancet, 1995